amgen glp 1 GLP-1 treatments are changing the game—not just for weight loss, but for overall metabolic health. Originally developed for type 2 diabetes, these medications are now helping people improve blood sugar control, reduce Amgen taking different path to

Our clinicians provide continuous monitoring and support to help you navigate these hurdles

Total Medicaid drug spending rose to $6 billion in 2025 from $4.8 billion in 2022, according to data provided by the Pennsylvania Department of Human Services

As some people have already noticed, the drugs appear to cut the risk for some substance use disorders, including addictions to opioids, alcohol, stimulants and sedatives

GLP-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data

Wiley Online Library

GIP receptor activation in the brain may contribute to appetite regulation through mechanisms distinct from GLP-1 signaling, potentially explaining tirzepatide's superior weight loss compared to GLP-1 monoagonists